Case Report of Sacituzumab Govitecan-hziy-Induced Neutropenia in a Patient With Metastatic Triple-Negative Breast Cancer and a Uridine Diphosphate Glucuronosyltransferase Family 1 Member A1 Poor Metabolizer Genotype
Last Updated: Thursday, May 12, 2022
This case discusses clinical implications of the uridine diphosphate glucuronosyltransferase family 1 member A1*28/*28 genotype in patients receiving sacituzumab govitecan-hziy.
Advertisement
News & Literature Highlights